MAPK3 and hepatocellular carcinoma: Additionally, we observed that APPLE-mediated ERK1/2 activation is independent of RAS mutational status, highlighting its relevance as a broadly active oncogenic mechanism even in RAS wild-type tumors, which comprise the vast majority of HCC cases (Fig. S2C&D).